Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy

The deposition of amyloid-β (Aβ) peptides in the walls of leptomeningeal and cortical blood vessels as cerebral amyloid angiopathy (CAA) is present in normal ageing and the majority of Alzheimer’s disease (AD) brains. The failure of clearance mechanisms to eliminate Aβ from the brain contributes to the development of sporadic CAA and AD. Here, we investigated the effects of CAA and ageing on the pattern of perivascular drainage of solutes in the brains of naïve mice and in the Tg2576 mouse model of AD. We report that drainage of small molecular weight dextran along cerebrovascular basement membranes is impaired in the hippocampal capillaries and arteries of 22-month-old wild-type mice compared to 3- and 7-month-old animals, which was associated with age-dependent changes in capillary density. Age-related alterations in the levels of laminin, fibronectin and perlecan in vascular basement membranes were also noted in wild-type mice. Furthermore, dextran was observed in the walls of veins of Tg2576 mice in the presence of CAA, suggesting that deposition of Aβ in vessel walls disrupts the normal route of elimination of solutes from the brain parenchyma. These data support the hypothesis that perivascular solute drainage from the brain is altered both in the ageing brain and as a consequence of CAA. These findings have implications for the success of therapeutic strategies for the treatment of AD that rely upon the health of the ageing cerebral vasculature.

[1]  S. Love,et al.  SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease , 2008 .

[2]  R. Weller,et al.  Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.

[3]  R O Weller,et al.  Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.

[4]  David M Holtzman,et al.  Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition , 2008, The Journal of Neuroscience.

[5]  N. Inestrosa,et al.  Laminin inhibits amyloid-β-peptide fibrillation , 1996, Neuroscience Letters.

[6]  L. Kjellén,et al.  Altered Processing of Fibronectin in Mice Lacking Heparin , 2001, The Journal of Biological Chemistry.

[7]  L. Mucke,et al.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.

[8]  P. Hutchins,et al.  The microcirculation in experimental hypertension and aging. , 1996, Cardiovascular research.

[9]  S. D. Preston,et al.  Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid β from the human brain , 2003, Neuropathology and applied neurobiology.

[10]  M. Staufenbiel,et al.  Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice , 2007, Neurobiology of Aging.

[11]  E. Burns,et al.  Changes with age in cerebral capillary morphology , 1981, Neurobiology of Aging.

[12]  T. Krieg,et al.  Laminins: a family of diverse multifunctional molecules of basement membranes. , 1996, The Journal of investigative dermatology.

[13]  P. Wesseling,et al.  Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques , 2002, Neurobiology of Aging.

[14]  N. Inestrosa,et al.  Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[15]  C. Patlak,et al.  Drainage of interstitial fluid from different regions of rat brain. , 1984, The American journal of physiology.

[16]  H. Nonaka,et al.  A study on the microvasculature of the cerebral cortex. Fundamental architecture and its senile change in the frontal cortex. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[17]  H. Cserr,et al.  Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. , 1981, The American journal of physiology.

[18]  H. Vanderstichele,et al.  Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in Neurons , 2000 .

[19]  T. Samorajski,et al.  Age-related changes in rat brain capillaries , 1983, Neurobiology of Aging.

[20]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Englund,et al.  Differential deposition of amyloid β peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia , 2006, Acta Neuropathologica.

[22]  Phillip B. Jones,et al.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.

[23]  Y. Kiuchi,et al.  Type IV collagen prevents amyloid β-protein fibril formation , 2002 .

[24]  David R. Riddle,et al.  Microvascular plasticity in aging , 2003, Ageing Research Reviews.

[25]  D. Reboussin,et al.  Cerebral Microvascular Alterations in Aging, Leukoaraiosis, and Alzheimer's Disease a , 1997, Annals of the New York Academy of Sciences.

[26]  M. Ghazizadeh,et al.  Interaction between β-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer’s disease , 2009, Journal of Clinical Neuroscience.

[27]  R. Deane,et al.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.

[28]  R O Weller,et al.  Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.

[29]  J. Couchman,et al.  Still More Complexity in Mammalian Basement Membranes , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  N. Patel,et al.  Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis , 2004, Neuroscience Letters.

[31]  M. Moskowitz,et al.  Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.

[32]  L. Ailles,et al.  Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[33]  N. Müller,et al.  Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease , 2010, International journal of Alzheimer's disease.

[34]  I. Pandrea,et al.  Implications for Therapy , 2012 .

[35]  J. Whitelock,et al.  Perlecan: how does one molecule do so many things? , 2006, Cellular and Molecular Life Sciences CMLS.

[36]  Xiaoping Xu,et al.  Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities. , 2011, Matrix biology : journal of the International Society for Matrix Biology.

[37]  N. Inestrosa,et al.  Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide , 2002, Peptides.

[38]  M. Scheunemann,et al.  Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice , 2006, International Journal of Developmental Neuroscience.

[39]  H. Tanila,et al.  Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice , 2007, Brain Research.

[40]  Yong-An Chung,et al.  Hypoperfusion and Ischemia in Cerebral Amyloid Angiopathy Documented by 99mTc-ECD Brain Perfusion SPECT , 2009, Journal of Nuclear Medicine.

[41]  R N Kalaria,et al.  Cerebral vessels in ageing and Alzheimer's disease. , 1996, Pharmacology & therapeutics.

[42]  R. Carare,et al.  SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .

[43]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[44]  Brian J Bacskai,et al.  Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.

[45]  R. Weller,et al.  Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. , 2004, Panminerva medica.

[46]  R. Roos,et al.  Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.

[47]  R. Timpl,et al.  Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes , 1999, The Journal of cell biology.

[48]  N. Inestrosa,et al.  Laminin inhibits amyloid-beta-peptide fibrillation. , 1996, Neuroscience letters.

[49]  S. Love,et al.  Angiotensin‐converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE‐1 to cerebral amyloid angiopathy , 2008, Neuropathology and applied neurobiology.

[50]  L. Launer,et al.  Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.

[51]  V. Perry,et al.  Mechanisms to explain the reverse perivascular transport of solutes out of the brain. , 2006, Journal of theoretical biology.

[52]  Robia G. Pautler,et al.  Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[53]  W. Halfter,et al.  Agrin Binds to β-Amyloid (Aβ), Accelerates Aβ Fibril Formation, and Is Localized to Aβ Deposits in Alzheimer's Disease Brain , 2000, Molecular and Cellular Neuroscience.

[54]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[55]  R. Timpl Macromolecular organization of basement membranes. , 1996, Current opinion in cell biology.

[56]  D. Wilcock,et al.  Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage , 2004, Journal of Neuroinflammation.

[57]  E. Fifková,et al.  Effect of age on blood vessels and neurovascular appositions in the rat dentate fascia , 1990, Neurobiology of Aging.

[58]  Reinhard Schliebs,et al.  Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain , 2009, International Journal of Developmental Neuroscience.

[59]  Karl J. Friston,et al.  Decreases in Regional Cerebral Blood Flow with Normal Aging , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  H. Weiner,et al.  Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells , 2006, Nature Medicine.

[61]  M. Staufenbiel,et al.  Cerebral hemorrhage after passive anti-Abeta immunotherapy. , 2002, Science.

[62]  T. Wight,et al.  Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. , 1997, Journal of neurochemistry.

[63]  Y. Kiuchi,et al.  Disassembly of amyloid beta-protein fibril by basement membrane components. , 2002, Life Science.

[64]  S. Younkin,et al.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  D. Mann,et al.  Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen , 2006 .

[66]  T. Ichimura,et al.  Distribution of extracellular tracers in perivascular spaces of the rat brain , 1991, Brain Research.

[67]  A. Danek,et al.  Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels , 2004, BMC Neuroscience.

[68]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[69]  K. Jellinger,et al.  Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage , 2007, European journal of neurology.

[70]  Ping Zhou,et al.  NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  Y. Kiuchi,et al.  Disassembly of amyloid β-protein fibril by basement membrane components , 2002 .

[72]  Mikio Shoji,et al.  Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.

[73]  I. Ferrer,et al.  Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis , 2006 .

[74]  Y. Kiuchi,et al.  Type IV collagen prevents amyloid beta-protein fibril formation. , 2002, Life sciences.

[75]  Irene Otte-Höller,et al.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.

[76]  D. Abrahamson,et al.  Basement membrane proteoglycans and development. , 1993, Kidney international.

[77]  L. S. Perlmutter Microvascular pathology and vascular basement membrane components in Alzheimer's disease , 1994, Molecular Neurobiology.